Literature DB >> 803102

The effect of chemotherapy on the kinetics and proliferative capacity of normal and tumorous tissues in vivo.

S H Rosenoff1, J M Bull, R C Young.   

Abstract

The proliferative state of a given tissue is a major determinant of its sensitivity to both phase-specific and cycle-specific chemotherapeutic agents. To study the extent of injury induced by antitumor agents to normal and tumorous tissues, a technique for following DNA synthesis as reflected in the incorporation of tritiated thymidine (3H-TdR) into DNA was compared to the conventional radioautographic technique of the labeling index (LI) and to the functional kinetic technique of granulocyte colony formation in vitro. Alterations in DNA synthesis induced by a single dose of cyclophosphamide in normal and tumorous tissues in vivo paralleled in many respects the changes seen when the more time-consuming techniques of the LI or granulocyte colony formation were employed. However, the recovery of granulocyte colony formation after cyclophosphamide therapy lagged behind the recovery of DNA synthesis in the bone marrow, obscuring a kinetic event of potential therapeutic significance. The determination of DNA synthesis simultaneously in normal and tumorous tissues in vivo was easy to perform and supplied therapeutically pertinent results comparatively quickly.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 803102

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  Increased infiltration by monocytes in delayed type hypersensitivity site following cyclophosphamide treatment.

Authors:  G Milon; G Marchal
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

2.  Reaction of human granulopoiesis to high-dose cyclophosphamide therapy.

Authors:  H P Lohrmann; W Schreml; T M Fliedner; H Heimpel
Journal:  Blut       Date:  1979-01-22

3.  Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion.

Authors:  C E Myers; R C Young; B A Chabner
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.